TR

Tanmoy Roy

Active Director Additional Director DIN 10626328
DIN 10626328 First appointment May 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Tanmoy Roy

Data last updated:

Tanmoy Roy is an Additional Director at Dillons Hospital Private Limited (since 2024). The company operates in Healthcare.

DIN 10626328
Primary Designation Additional Director
Industry Healthcare
First Appointment 09 May 2024
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dillons Hospital Private Limited U85191WB2007PTC116329
Additional Director09 May 20242007Active

Board colleagues of Tanmoy Roy

Directorship timeline

Open interactive timeline →
Dillons Hospital Private Limited
Premium access

Shareholding and investment profile for Tanmoy Roy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tanmoy Roy

Tanmoy Roy currently holds 1 directorship: Dillons Hospital Private Limited (Additional Director, since 09 May 2024).

Tanmoy Roy was first appointed on 09 May 2024 as Additional Director at Dillons Hospital Private Limited.

The current boards of Tanmoy Roy's companies include Amit Kumar Dutta (Dillons Hospital Private Limited), Dibyendu Kumar Ray (Dillons Hospital Private Limited), Jayanta Das (Dillons Hospital Private Limited), Jayanta Das (Dillons Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available